Tonix Pharmaceuticals Holding Corp.·5

Feb 11, 5:18 PM ET

SAENGER BRADLEY 5

5 · Tonix Pharmaceuticals Holding Corp. · Filed Feb 11, 2022

Insider Transaction Report

Form 5
Period: 2021-12-31
SAENGER BRADLEY
Chief Financial Officer
Transactions
  • Award

    Common Stock, par value $0.001

    2021-06-30$0.58/sh+18,248$10,58419,645 total
Footnotes (1)
  • [F1]Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2020 Employee Stock Purchase Plan.

Documents

1 file
  • 5
    ownership.xmlPrimary

    BENEFICIAL OWNERSHIP